CAD 0.22
(-6.52%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 8.31 Million USD | -18.84% |
2022 | 10.24 Million USD | -34.33% |
2021 | 15.59 Million USD | -25.93% |
2020 | 21.05 Million USD | -36.17% |
2019 | 32.99 Million USD | -19.23% |
2018 | 40.84 Million USD | 19692.74% |
2017 | -208.47 Thousand USD | -321307.76% |
2016 | -64.86 USD | 12.82% |
2015 | -74.40 USD | 29.84% |
2014 | -106.04 USD | 95.93% |
2013 | -2606.98 USD | 98.89% |
2012 | -234.6 Thousand USD | -1118.59% |
2011 | -19.25 Thousand USD | 96.28% |
2010 | -518.06 Thousand USD | -414.91% |
2009 | -100.61 Thousand USD | -297.73% |
2008 | 50.88 Thousand USD | 146.35% |
2007 | -109.77 Thousand USD | 74.9% |
2006 | -437.33 Thousand USD | -251.66% |
2005 | -124.36 Thousand USD | -62.18% |
2004 | -76.68 Thousand USD | -4970.04% |
2003 | -1512.45 USD | 96.37% |
2002 | -41.62 Thousand USD | -128.22% |
2001 | 147.52 Thousand USD | 13.83% |
2000 | 129.59 Thousand USD | 10.93% |
1999 | 116.82 Thousand USD | 54.39% |
1998 | 75.67 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 9.5 Million USD | 0.0% |
2023 Q2 | 7.64 Million USD | -16.92% |
2023 Q1 | 9.19 Million USD | -10.2% |
2023 FY | 8.31 Million USD | -18.84% |
2023 Q4 | 8.31 Million USD | 5.1% |
2023 Q3 | 7.91 Million USD | 3.51% |
2022 Q1 | 14.56 Million USD | -6.61% |
2022 Q3 | 11.43 Million USD | -12.91% |
2022 Q2 | 13.12 Million USD | -9.88% |
2022 Q4 | 10.24 Million USD | -10.4% |
2022 FY | 10.24 Million USD | -34.33% |
2021 Q4 | 15.59 Million USD | -13.06% |
2021 FY | 15.59 Million USD | -25.93% |
2021 Q2 | 18.65 Million USD | -4.18% |
2021 Q1 | 19.46 Million USD | -7.56% |
2021 Q3 | 17.94 Million USD | -3.81% |
2020 FY | 21.05 Million USD | -36.17% |
2020 Q1 | 32.43 Million USD | -1.69% |
2020 Q2 | 29.5 Million USD | -9.05% |
2020 Q4 | 21.05 Million USD | -20.16% |
2020 Q3 | 26.37 Million USD | -10.6% |
2019 Q2 | 38.33 Million USD | -16.33% |
2019 Q3 | 36.71 Million USD | -4.21% |
2019 FY | 32.99 Million USD | -19.23% |
2019 Q4 | 32.99 Million USD | -10.15% |
2019 Q1 | 45.81 Million USD | 12.16% |
2018 Q1 | -21.17 Million USD | -10059.36% |
2018 FY | 40.84 Million USD | 19692.74% |
2018 Q2 | -12.56 Million USD | 40.67% |
2018 Q3 | -3.81 Million USD | 69.6% |
2018 Q4 | 40.84 Million USD | 1169.32% |
2017 Q2 | -416.96 Thousand USD | -1236796.68% |
2017 Q1 | -33.71 USD | 48.03% |
2017 FY | -208.47 Thousand USD | -321307.76% |
2017 Q4 | -208.47 Thousand USD | 38.41% |
2017 Q3 | -338.51 Thousand USD | 18.81% |
2016 Q3 | -32.05 USD | 94.73% |
2016 Q1 | -39.83 USD | 46.47% |
2016 FY | -64.86 USD | 12.82% |
2016 Q4 | -64.86 USD | -102.37% |
2016 Q2 | -607.87 USD | -1426.22% |
2015 Q4 | -74.40 USD | -9628.43% |
2015 FY | -74.40 USD | 29.84% |
2015 Q3 | -0.76 USD | 98.42% |
2015 Q2 | -48.43 USD | 80.97% |
2015 Q1 | -254.49 USD | -139.99% |
2014 FY | -106.04 USD | 95.93% |
2014 Q4 | -106.04 USD | 46.26% |
2014 Q2 | -145.75 USD | 61.89% |
2014 Q1 | -382.44 USD | 85.33% |
2014 Q3 | -197.34 USD | -35.4% |
2013 FY | -2606.98 USD | 98.89% |
2013 Q4 | -2606.98 USD | 64.03% |
2013 Q1 | -126.57 Thousand USD | 46.05% |
2013 Q3 | -7247.52 USD | 83.16% |
2013 Q2 | -43.04 Thousand USD | 65.99% |
2012 Q2 | -2457.58 USD | 87.05% |
2012 Q1 | -18.98 Thousand USD | 1.39% |
2012 Q3 | -43.69 Thousand USD | -1677.97% |
2012 Q4 | -234.6 Thousand USD | -436.91% |
2012 FY | -234.6 Thousand USD | -1118.59% |
2011 FY | -19.25 Thousand USD | 96.28% |
2011 Q1 | -360.43 Thousand USD | 30.43% |
2011 Q2 | -109.53 Thousand USD | 69.61% |
2011 Q3 | -28.6 Thousand USD | 73.89% |
2011 Q4 | -19.25 Thousand USD | 32.69% |
2010 Q3 | -539.65 Thousand USD | -649.38% |
2010 Q2 | -72.01 Thousand USD | -735.73% |
2010 Q1 | -8616.76 USD | 91.44% |
2010 Q4 | -518.06 Thousand USD | 4.0% |
2010 FY | -518.06 Thousand USD | -414.91% |
2009 Q2 | -1756.54 USD | -127.11% |
2009 FY | -100.61 Thousand USD | -297.73% |
2009 Q4 | -100.61 Thousand USD | -3.54% |
2009 Q3 | -97.17 Thousand USD | -5431.91% |
2009 Q1 | 6480.00 USD | -87.26% |
2008 Q3 | -5021.27 USD | 68.76% |
2008 Q4 | 50.88 Thousand USD | 1113.35% |
2008 FY | 50.88 Thousand USD | 146.35% |
2008 Q1 | -16.84 Thousand USD | 84.66% |
2008 Q2 | -16.07 Thousand USD | 4.58% |
2007 Q4 | -109.77 Thousand USD | 74.84% |
2007 FY | -109.77 Thousand USD | 74.9% |
2007 Q1 | -1.03 Million USD | -136.48% |
2007 Q2 | -937.35 Thousand USD | 9.37% |
2007 Q3 | -436.34 Thousand USD | 53.45% |
2006 Q3 | -341.31 Thousand USD | -25.65% |
2006 FY | -437.33 Thousand USD | -251.66% |
2006 Q1 | -50.77 Thousand USD | 59.17% |
2006 Q2 | -271.64 Thousand USD | -435.01% |
2006 Q4 | -437.33 Thousand USD | -28.13% |
2005 FY | -124.36 Thousand USD | -62.18% |
2005 Q4 | -124.36 Thousand USD | -144.48% |
2005 Q2 | -23.01 Thousand USD | 65.16% |
2005 Q1 | -66.04 Thousand USD | 13.87% |
2005 Q3 | -50.86 Thousand USD | -121.07% |
2004 Q3 | -70.66 Thousand USD | -738.71% |
2004 FY | -76.68 Thousand USD | -4970.04% |
2004 Q1 | -8035.01 USD | -431.26% |
2004 Q2 | -8425.40 USD | -4.86% |
2004 Q4 | -76.68 Thousand USD | -8.51% |
2003 Q1 | -15.74 Thousand USD | 62.19% |
2003 Q2 | -22.32 Thousand USD | -41.86% |
2003 FY | -1512.45 USD | 96.37% |
2003 Q3 | -5496.00 USD | 75.39% |
2003 Q4 | -1512.45 USD | 72.48% |
2002 FY | -41.62 Thousand USD | -128.22% |
2002 Q1 | 99.94 Thousand USD | -32.25% |
2002 Q2 | 114.73 Thousand USD | 14.79% |
2002 Q3 | 133.6 Thousand USD | 16.44% |
2002 Q4 | -41.62 Thousand USD | -131.16% |
2001 Q1 | 146.36 Thousand USD | 12.94% |
2001 Q4 | 147.52 Thousand USD | -0.73% |
2001 FY | 147.52 Thousand USD | 13.83% |
2001 Q2 | 139.07 Thousand USD | -4.98% |
2001 Q3 | 148.6 Thousand USD | 6.85% |
2000 Q3 | 114.9 Thousand USD | -0.4% |
2000 Q1 | 118.97 Thousand USD | 1.84% |
2000 Q2 | 115.36 Thousand USD | -3.04% |
2000 FY | 129.59 Thousand USD | 10.93% |
2000 Q4 | 129.59 Thousand USD | 12.79% |
1999 Q3 | 111.28 Thousand USD | -17.96% |
1999 Q2 | 135.64 Thousand USD | 156.48% |
1999 Q1 | 52.88 Thousand USD | 0.0% |
1999 Q4 | 116.82 Thousand USD | 4.98% |
1999 FY | 116.82 Thousand USD | 54.39% |
1998 FY | 75.67 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aion Therapeutic Inc. | 826.13 Thousand CAD | -906.479% |
Ayurcann Holdings Corp. | 69.97 Thousand CAD | -11781.949% |
Blueberries Medical Corp. | -805.35 Thousand CAD | 1132.449% |
The BC Bud Corporation | 225.15 Thousand CAD | -3592.986% |
BioNxt Solutions Inc. | 4.53 Million CAD | -83.531% |
CordovaCann Corp. | 6.13 Million CAD | -35.62% |
Christina Lake Cannabis Corp. | 4.62 Million CAD | -79.66% |
Captor Capital Corp. | -5.41 Million CAD | 253.679% |
City View Green Holdings Inc. | 1.49 Million CAD | -454.981% |
1CM Inc. | 3.31 Million CAD | -150.824% |
Global Hemp Group Inc. | 3.55 Million CAD | -134.082% |
Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 42.615% |
IM Cannabis Corp. | 11.96 Million CAD | 30.53% |
Lobe Sciences Ltd. | 192.35 Thousand CAD | -4222.781% |
Maple Leaf Green World Inc. | 2.47 Million CAD | -236.106% |
Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 240.573% |
Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 1951.233% |
Ovation Science Inc. | 143.76 Thousand CAD | -5683.613% |
Pharmadrug Inc. | 1.2 Million CAD | -589.063% |
Captiva Verde Wellness Corp. | 186.26 Thousand CAD | -4364.12% |
RAMM Pharma Corp. | -4.71 Million CAD | 276.473% |
RIV Capital Inc. | -101.38 Million CAD | 108.201% |
Revive Therapeutics Ltd. | -797.85 Thousand CAD | 1142.159% |
Red White & Bloom Brands Inc. | 259.87 Million CAD | 96.8% |
SLANG Worldwide Inc. | 20.83 Million CAD | 60.085% |
1933 Industries Inc. | 16.47 Million CAD | 49.541% |
Red Light Holland Corp. | -13.56 Million CAD | 161.313% |
Top Strike Resources Corp. | 13.24 Million CAD | 37.238% |
Xebra Brands Ltd. | -102.41 Thousand CAD | 8218.562% |
Adastra Holdings Ltd. | 2.2 Million CAD | -277.208% |